175 related articles for article (PubMed ID: 12519870)
1. The inhibition of growth hormone secretion presented in obesity is not mediated by the high leptin levels: a study in human leptin deficiency patients.
Ozata M; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 2003 Jan; 88(1):312-6. PubMed ID: 12519870
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
De Marinis L; Bianchi A; Mancini A; Gentilella R; Perrelli M; Giampietro A; Porcelli T; Tilaro L; Fusco A; Valle D; Tacchino RM
J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
[TBL] [Abstract][Full Text] [Related]
3. Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRH + GHRP-6 test.
Kelestimur F; Popovic V; Leal A; Van Dam PS; Torres E; Perez Mendez LF; Greenman Y; Koppeschaar HP; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 2006 Jun; 64(6):667-71. PubMed ID: 16712669
[TBL] [Abstract][Full Text] [Related]
4. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
Cordido F; Peino R; Peñalva A; Alvarez CV; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1996 Mar; 81(3):914-8. PubMed ID: 8772550
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
6. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level.
Popovic V; Damjanovic S; Micic D; Djurovic M; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1995 Mar; 80(3):942-7. PubMed ID: 7883854
[TBL] [Abstract][Full Text] [Related]
7. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
Cordido F; Peñalva A; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone response to GHRH, GHRP-6 and GHRH + GHRP-6 in patients with polycystic ovary syndrome.
Micić D; Kendereski A; Popović V; Sumarac M; Zorić S; Macut D; Dieguez C; Casanueva F
Clin Endocrinol (Oxf); 1996 Oct; 45(4):385-90. PubMed ID: 8959075
[TBL] [Abstract][Full Text] [Related]
9. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
[TBL] [Abstract][Full Text] [Related]
10. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
[TBL] [Abstract][Full Text] [Related]
11. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone.
Van den Berghe G; Wouters P; Carlsson L; Baxter RC; Bouillon R; Bowers CY
J Clin Endocrinol Metab; 1998 Sep; 83(9):3062-70. PubMed ID: 9745404
[TBL] [Abstract][Full Text] [Related]
12. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults.
Popovic V; Leal A; Micic D; Koppeschaar HP; Torres E; Paramo C; Obradovic S; Dieguez C; Casanueva FF
Lancet; 2000 Sep; 356(9236):1137-42. PubMed ID: 11030292
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH) response to GH-releasing peptide-6 in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion.
Catalina PF; Mallo F; Andrade MA; García-Mayor RV; Diéguez C
J Clin Endocrinol Metab; 1998 Oct; 83(10):3663-7. PubMed ID: 9768681
[TBL] [Abstract][Full Text] [Related]
14. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection.
Pombo M; Barreiro J; Peñalva A; Peino R; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1995 Nov; 80(11):3180-4. PubMed ID: 7593423
[TBL] [Abstract][Full Text] [Related]
15. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women.
Tolle V; Kadem M; Bluet-Pajot MT; Frere D; Foulon C; Bossu C; Dardennes R; Mounier C; Zizzari P; Lang F; Epelbaum J; Estour B
J Clin Endocrinol Metab; 2003 Jan; 88(1):109-16. PubMed ID: 12519838
[TBL] [Abstract][Full Text] [Related]
16. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
Veldhuis JD; Evans WS; Bowers CY
J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
[TBL] [Abstract][Full Text] [Related]
17. Preserved growth hormone (GH) secretion in aged and very old subjects after testing with the combined stimulus GH-releasing hormone plus GH-releasing hexapeptide-6.
Micic D; Popovic V; Doknic M; Macut D; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1998 Jul; 83(7):2569-72. PubMed ID: 9661645
[TBL] [Abstract][Full Text] [Related]
18. Gonadal status and body mass index jointly determine growth hormone (GH)-releasing hormone/GH-releasing peptide synergy in healthy men.
Paulo RC; Cosma M; Soares-Welch C; Bailey JN; Mielke KL; Miles JM; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2008 Mar; 93(3):944-50. PubMed ID: 18073313
[TBL] [Abstract][Full Text] [Related]
19. The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6.
Popovic V; Pekic S; Golubicic I; Doknic M; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 2002 May; 87(5):2095-9. PubMed ID: 11994347
[TBL] [Abstract][Full Text] [Related]
20. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
Peino R; Cordido F; Peñalva A; Alvarez CV; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
